European Respiratory Society International Congress, Madrid, 2019: nontuberculous mycobacterial pulmonary disease highlights.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
26
05
2020
accepted:
03
08
2020
entrez:
30
10
2020
pubmed:
31
10
2020
medline:
31
10
2020
Statut:
epublish
Résumé
Once overlooked, awareness of nontuberculous mycobacterial pulmonary disease (NTM-PD) is rapidly rising, in line with increasing prevalence worldwide. The European Respiratory Society (ERS) International Congress 2019, held in Madrid, Spain, provided a platform for invigorating discussions and exciting new research in the field. This article explores approaches being taken to combat NTM-PD with a focus not only on novel prevalence and risk factor data, but also on emerging antimicrobials and their routes of delivery, and other potential treatment options in early clinical development.
Identifiants
pubmed: 33123559
doi: 10.1183/23120541.00317-2020
pii: 00317-2020
pmc: PMC7569164
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: J.D. Chalmers reports grants and personal fees from AstraZeneca and Boehringer Ingelheim, grants from Gilead Sciences, grants and personal fees from GlaxoSmithKline, grants from Grifols, grants and personal fees from Insmed, and personal fees from Chiesi, Novartis and Zambon, outside the submitted work. Conflict of interest: C. Balavoine has nothing to disclose. Conflict of interest: P.F. Castellotti has nothing to disclose. Conflict of interest: C. Hügel reports personal fees from Boehringer Ingelheim and PulmonX, and nonfinancial support from Mukoviszidose e.V., Gilead, Insmed and Novartis, outside the submitted work. Conflict of interest: A. Payet has nothing to disclose. Conflict of interest: D. Wat reports grants and personal fees from Chiesi and Insmed, and personal fees from GlaxoSmithKline, outside the submitted work. Conflict of interest: G. Rohde reports personal fees from Boehringer Ingelheim, Chiesi, Essex Pharma, GlaxoSmithKline, Grifols, Insmed, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Solvay and Vertex, outside the submitted work.
Références
Thorax. 2013 Mar;68(3):256-62
pubmed: 22781123
Int J Tuberc Lung Dis. 2012;16(3):408-14
pubmed: 22230733
Drug Discov Today. 2018 Aug;23(8):1502-1519
pubmed: 29635026
BMC Infect Dis. 2019 Dec 17;19(1):1061
pubmed: 31847834
PLoS One. 2018 Jun 13;13(6):e0197976
pubmed: 29897938
Ann Am Thorac Soc. 2016 Sep;13(9):S379-84
pubmed: 27627485
Eur Respir J. 2017 Feb 15;49(2):
pubmed: 28182571
Pediatr Infect Dis J. 2018 Apr;37(4):336-338
pubmed: 28885458
BMC Pulm Med. 2019 Aug 1;19(1):140
pubmed: 31370826
Tuberc Respir Dis (Seoul). 2019 Jan;82(1):15-26
pubmed: 30574687
Ann Am Thorac Soc. 2018 Oct;15(10):1169-1176
pubmed: 30213194
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64
pubmed: 29054853
Eur Respir J. 2013 Dec;42(6):1604-13
pubmed: 23598956
Emerg Microbes Infect. 2019;8(1):1043-1053
pubmed: 31287781
Eur Respir J. 2016 Sep;48(3):928-31
pubmed: 27288038
Chest. 2017 Jul;152(1):120-142
pubmed: 28461147
Clin Microbiol Rev. 2012 Jul;25(3):545-82
pubmed: 22763637
Front Microbiol. 2019 Aug 23;10:1977
pubmed: 31507579
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416
pubmed: 17277290
Ann Am Thorac Soc. 2017 Jul;14(7):1112-1119
pubmed: 28387532
Thorax. 2016 Jan;71 Suppl 1:i1-22
pubmed: 26666259
Clin Chest Med. 2015 Mar;36(1):13-34
pubmed: 25676516
Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33
pubmed: 30151192
Thorax. 2015 Jul;70(7):677-82
pubmed: 25911222
Eur Respir J. 2017 Sep 20;50(3):
pubmed: 28931659
Immune Netw. 2009 Apr;9(2):46-52
pubmed: 20107543
Clin Chest Med. 2015 Mar;36(1):91-9
pubmed: 25676522
J Trop Med. 2019 Jul 3;2019:1273235
pubmed: 31354843
Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569
pubmed: 30216086
BMJ Open Respir Res. 2020 Apr;7(1):
pubmed: 32332023
Eur Respir J. 2017 Sep 27;50(3):
pubmed: 28954780
Respirology. 2016 Aug;21(6):1015-25
pubmed: 27009804
Clin Chest Med. 2015 Mar;36(1):55-66
pubmed: 25676519
Thorac Surg Clin. 2019 Feb;29(1):95-108
pubmed: 30454926
Tuberc Respir Dis (Seoul). 2019 Apr;82(2):94-101
pubmed: 30302953
Emerg Infect Dis. 2017 Mar;23(3):468-476
pubmed: 28221106
Int J Chron Obstruct Pulmon Dis. 2017 Aug 22;12:2487-2506
pubmed: 28860743
Eur Respir J. 2017 Sep 27;50(3):
pubmed: 28954776
Am J Respir Crit Care Med. 2010 Mar 1;181(5):514-21
pubmed: 20007929
Eur Respir J. 2019 Jul 18;54(1):
pubmed: 31000676
Biomed Res Int. 2015;2015:197950
pubmed: 26106603
Eur Respir J. 2018 May 10;51(5):
pubmed: 29545278
BMJ Open Respir Res. 2020 Apr;7(1):
pubmed: 32332022
J Cyst Fibros. 2020 Mar;19(2):225-231
pubmed: 31129068